MedPath

The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery

Not Applicable
Completed
Conditions
Colon Cancer
Rectal Cancer
Colon Adenocarcinoma
Rectal Adenocarcinoma
Interventions
Device: Monofix
Registration Number
NCT05872334
Lead Sponsor
Samsung Medical Center
Brief Summary

This clinical trial aims to evaluate the safety and feasibility of mid-line fascial suturing using MONOFIX sutures in patients undergoing minimally invasive surgery for colorectal cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Colorectal adenocarcinoma
  • Elective (or planned) curative surgery
  • Laparoscopic surgery
  • Midline incision less than 10 cm
Exclusion Criteria
  • Previous laparotomy with midline incision more than 10cm.
  • Systemic chemotherapy for any cause within the last 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MonofixMonofixIn patients who underwent laparoscopic colorectal cancer surgery, the fascial closure of the midline incision was performed using a running suture type with Monofix, one of the barbed sutures.
Primary Outcome Measures
NameTimeMethod
Incisional hernia18 months from surgery

Incisional hernia diagnosed by CT scan.

Secondary Outcome Measures
NameTimeMethod
Wound bleeding1 month from surgery

In cases where bleeding was visually observed from the wound or a hematoma was observed on the CT scan.

Wound dehiscence1 month from surgery

In cases where the fascial closure was incomplete, causing part of the abdominal organs to protrude outside the abdomen, requiring surgical treatment.

Wound infection1 month from surgery

In cases where microorganisms were identified in the wound culture results.

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Gangnam, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath